Böcker i Haematology and Blood Transfusion Hamatologie und Bluttransfusion-serien

Evaluation of molecular and immunologic leukemia cell markers has provided a better understanding of residual leukemia in clinical remission, as a prognostic factor and in monitoring the effectiveness of the antileukemic strategy.